| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 216,266,306 | 211,993,024 | 163,187,760 | | Cost of Revenue |
-
|
-
|
-
| | | Gross Profit | 216,266,306 | 211,993,024 | 163,187,760 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 91,709,443 | 94,735,455 | 82,700,951 | | Non Recurring |
-
| (637,766) | 35,648 | | Others | 4,083,901 | 184,113 |
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 120,472,962 | 117,711,222 | 80,451,160 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
| (1,142,060) | | Earnings Before Interest And Taxes | 120,472,962 | 117,711,222 | 78,858,878 | | Interest Expense | 122,569,186 | 101,445,988 | 67,327,378 | | Income Before Tax | (2,096,224) | 16,265,235 | 11,531,500 | | Income Tax Expense | (1,016,394) | 2,260,902 | 2,517,812 | | Minority Interest |
-
|
-
| (450,222) | | | | Net Income From Continuing Ops | (1,079,830) | 14,004,333 | 9,013,688 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (1,079,830) | 14,004,333 | 9,013,688 | | Preferred Stock And Other Adjustments |
-
| (393,264) |
-
| | | Net Income Applicable To Common Shares | ($1,079,830) | $13,611,069 | $9,013,688 |
|
0.29% Nasdaq 
0.24 (1.92%) 
Income Statement
